Jennison Associates LLC Astrazeneca PLC Transaction History
Jennison Associates LLC
- $149 Billion
- Q1 2024
A detailed history of Jennison Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jennison Associates LLC holds 17,276,282 shares of AZN stock, worth $1.35 Billion. This represents 0.79% of its overall portfolio holdings.
Number of Shares
17,276,282
Previous 17,732,542
2.57%
Holding current value
$1.35 Billion
Previous $1.19 Billion
1.99%
% of portfolio
0.79%
Previous 0.9%
Shares
24 transactions
Others Institutions Holding AZN
# of Institutions
1,244Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Franklin Resources Inc San Mateo, CA17.2MShares$1.34 Billion0.38% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...